Healthcare Triangle is trading at $0.57 (-6.61%) after Nasdaq’s October 1, 2026 delisting determination over its failure to meet the $1 minimum bid-price rule.
- Prior reverse splits make it ineligible for a standard compliance period; Nasdaq says trading could be suspended October 12 unless Healthcare Triangle appeals by October 8.
- The company says it intends to request a hearing, which would stay suspension pending the panel’s decision.
- Broader indices are higher, making company-specific delisting risk the clearer explanation.